Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FPSGN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,747
Award facts
- Contract value 100% obligated
- $13,746.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,746.50 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Cosentyx (secukinumab) 300 mg pre-filled pens in 2 ml formulations. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication used to treat various autoimmune and inflammatory conditions, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need for specialty pharmaceutical products to support military healthcare requirements.
This delivery order represents a task order execution under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen Drug Corp serves as a critical vendor for military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's competitively awarded contracts with the Defense Logistics Agency demonstrate its capability to fulfill federal medical procurement requirements across multiple therapeutic domains in support of Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FPSGN?
SPE2DB25FPSGN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FPSGN worth?
The government has obligated $13,747 on SPE2DB25FPSGN.
Is contract SPE2DB25FPSGN an order under another contract?
Yes. SPE2DB25FPSGN is a delivery order under SPE2DB25D2203, an indefinite delivery contract.
Was contract SPE2DB25FPSGN competed?
The extent of competition for SPE2DB25FPSGN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award